Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Pulmonary Drug Delivery Devices Market Growth 2022-2028

  • LP 4845509
  • 127 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pulmonary Drug Delivery Devices will have significant change from previous year. According to our (LP Information) latest study, the global Pulmonary Drug Delivery Devices market size is USD million in 2022 from USD 2773.9 million in 2021, with a change of % between 2021 and 2022. The global Pulmonary Drug Delivery Devices market size will reach USD 3738.9 million in 2028, growing at a CAGR of 4.4% over the analysis period.

The United States Pulmonary Drug Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pulmonary Drug Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Pulmonary Drug Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pulmonary Drug Delivery Devices players cover Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Dry Powder Inhaler

Metered Dose Inhaler

Nebulizer

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Asthma

COPD

Cystic Fibrosis

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Boehringer Ingelheim GmbH

Novartis AG

GlaxoSmithKline

AstraZeneca

Teva Pharmaceutical Industries

Merck

MannKind

Bristol-Myers Squibb

Mylan N.V

Omron Corp

F. Hoffmann-La Roche

3M Healthcare

Sunovion Pharmaceuticals

Koninklijke Philips N.V

Gerresheimer AG

Bespak

AptarGroup

SHL Group

Nypro Healthcare

Hovione

Chiesi Farmaceutici S.P.A

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pulmonary Drug Delivery Devices Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pulmonary Drug Delivery Devices by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pulmonary Drug Delivery Devices by Country/Region, 2017, 2022 & 2028

2.2 Pulmonary Drug Delivery Devices Segment by Type

2.2.1 Dry Powder Inhaler

2.2.2 Metered Dose Inhaler

2.2.3 Nebulizer

2.3 Pulmonary Drug Delivery Devices Sales by Type

2.3.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2017-2022)

2.3.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pulmonary Drug Delivery Devices Sale Price by Type (2017-2022)

2.4 Pulmonary Drug Delivery Devices Segment by Application

2.4.1 Asthma

2.4.2 COPD

2.4.3 Cystic Fibrosis

2.4.4 Other

2.5 Pulmonary Drug Delivery Devices Sales by Application

2.5.1 Global Pulmonary Drug Delivery Devices Sale Market Share by Application (2017-2022)

2.5.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pulmonary Drug Delivery Devices Sale Price by Application (2017-2022)

3 Global Pulmonary Drug Delivery Devices by Company

3.1 Global Pulmonary Drug Delivery Devices Breakdown Data by Company

3.1.1 Global Pulmonary Drug Delivery Devices Annual Sales by Company (2020-2022)

3.1.2 Global Pulmonary Drug Delivery Devices Sales Market Share by Company (2020-2022)

3.2 Global Pulmonary Drug Delivery Devices Annual Revenue by Company (2020-2022)

3.2.1 Global Pulmonary Drug Delivery Devices Revenue by Company (2020-2022)

3.2.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Company (2020-2022)

3.3 Global Pulmonary Drug Delivery Devices Sale Price by Company

3.4 Key Manufacturers Pulmonary Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pulmonary Drug Delivery Devices Product Location Distribution

3.4.2 Players Pulmonary Drug Delivery Devices Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pulmonary Drug Delivery Devices by Geographic Region

4.1 World Historic Pulmonary Drug Delivery Devices Market Size by Geographic Region (2017-2022)

4.1.1 Global Pulmonary Drug Delivery Devices Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pulmonary Drug Delivery Devices Annual Revenue by Geographic Region

4.2 World Historic Pulmonary Drug Delivery Devices Market Size by Country/Region (2017-2022)

4.2.1 Global Pulmonary Drug Delivery Devices Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pulmonary Drug Delivery Devices Annual Revenue by Country/Region

4.3 Americas Pulmonary Drug Delivery Devices Sales Growth

4.4 APAC Pulmonary Drug Delivery Devices Sales Growth

4.5 Europe Pulmonary Drug Delivery Devices Sales Growth

4.6 Middle East & Africa Pulmonary Drug Delivery Devices Sales Growth

5 Americas

5.1 Americas Pulmonary Drug Delivery Devices Sales by Country

5.1.1 Americas Pulmonary Drug Delivery Devices Sales by Country (2017-2022)

5.1.2 Americas Pulmonary Drug Delivery Devices Revenue by Country (2017-2022)

5.2 Americas Pulmonary Drug Delivery Devices Sales by Type

5.3 Americas Pulmonary Drug Delivery Devices Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pulmonary Drug Delivery Devices Sales by Region

6.1.1 APAC Pulmonary Drug Delivery Devices Sales by Region (2017-2022)

6.1.2 APAC Pulmonary Drug Delivery Devices Revenue by Region (2017-2022)

6.2 APAC Pulmonary Drug Delivery Devices Sales by Type

6.3 APAC Pulmonary Drug Delivery Devices Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pulmonary Drug Delivery Devices by Country

7.1.1 Europe Pulmonary Drug Delivery Devices Sales by Country (2017-2022)

7.1.2 Europe Pulmonary Drug Delivery Devices Revenue by Country (2017-2022)

7.2 Europe Pulmonary Drug Delivery Devices Sales by Type

7.3 Europe Pulmonary Drug Delivery Devices Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pulmonary Drug Delivery Devices by Country

8.1.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2017-2022)

8.2 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type

8.3 Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices

10.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices

10.4 Industry Chain Structure of Pulmonary Drug Delivery Devices

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pulmonary Drug Delivery Devices Distributors

11.3 Pulmonary Drug Delivery Devices Customer

12 World Forecast Review for Pulmonary Drug Delivery Devices by Geographic Region

12.1 Global Pulmonary Drug Delivery Devices Market Size Forecast by Region

12.1.1 Global Pulmonary Drug Delivery Devices Forecast by Region (2023-2028)

12.1.2 Global Pulmonary Drug Delivery Devices Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pulmonary Drug Delivery Devices Forecast by Type

12.7 Global Pulmonary Drug Delivery Devices Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim GmbH

13.1.1 Boehringer Ingelheim GmbH Company Information

13.1.2 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Offered

13.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim GmbH Main Business Overview

13.1.5 Boehringer Ingelheim GmbH Latest Developments

13.2 Novartis AG

13.2.1 Novartis AG Company Information

13.2.2 Novartis AG Pulmonary Drug Delivery Devices Product Offered

13.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis AG Main Business Overview

13.2.5 Novartis AG Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Pulmonary Drug Delivery Devices Product Offered

13.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

13.4 AstraZeneca

13.4.1 AstraZeneca Company Information

13.4.2 AstraZeneca Pulmonary Drug Delivery Devices Product Offered

13.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AstraZeneca Main Business Overview

13.4.5 AstraZeneca Latest Developments

13.5 Teva Pharmaceutical Industries

13.5.1 Teva Pharmaceutical Industries Company Information

13.5.2 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Offered

13.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Teva Pharmaceutical Industries Main Business Overview

13.5.5 Teva Pharmaceutical Industries Latest Developments

13.6 Merck

13.6.1 Merck Company Information

13.6.2 Merck Pulmonary Drug Delivery Devices Product Offered

13.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Merck Main Business Overview

13.6.5 Merck Latest Developments

13.7 MannKind

13.7.1 MannKind Company Information

13.7.2 MannKind Pulmonary Drug Delivery Devices Product Offered

13.7.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 MannKind Main Business Overview

13.7.5 MannKind Latest Developments

13.8 Bristol-Myers Squibb

13.8.1 Bristol-Myers Squibb Company Information

13.8.2 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Offered

13.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bristol-Myers Squibb Main Business Overview

13.8.5 Bristol-Myers Squibb Latest Developments

13.9 Mylan N.V

13.9.1 Mylan N.V Company Information

13.9.2 Mylan N.V Pulmonary Drug Delivery Devices Product Offered

13.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Mylan N.V Main Business Overview

13.9.5 Mylan N.V Latest Developments

13.10 Omron Corp

13.10.1 Omron Corp Company Information

13.10.2 Omron Corp Pulmonary Drug Delivery Devices Product Offered

13.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Omron Corp Main Business Overview

13.10.5 Omron Corp Latest Developments

13.11 F. Hoffmann-La Roche

13.11.1 F. Hoffmann-La Roche Company Information

13.11.2 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Offered

13.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 F. Hoffmann-La Roche Main Business Overview

13.11.5 F. Hoffmann-La Roche Latest Developments

13.12 3M Healthcare

13.12.1 3M Healthcare Company Information

13.12.2 3M Healthcare Pulmonary Drug Delivery Devices Product Offered

13.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 3M Healthcare Main Business Overview

13.12.5 3M Healthcare Latest Developments

13.13 Sunovion Pharmaceuticals

13.13.1 Sunovion Pharmaceuticals Company Information

13.13.2 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Offered

13.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Sunovion Pharmaceuticals Main Business Overview

13.13.5 Sunovion Pharmaceuticals Latest Developments

13.14 Koninklijke Philips N.V

13.14.1 Koninklijke Philips N.V Company Information

13.14.2 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Offered

13.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Koninklijke Philips N.V Main Business Overview

13.14.5 Koninklijke Philips N.V Latest Developments

13.15 Gerresheimer AG

13.15.1 Gerresheimer AG Company Information

13.15.2 Gerresheimer AG Pulmonary Drug Delivery Devices Product Offered

13.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Gerresheimer AG Main Business Overview

13.15.5 Gerresheimer AG Latest Developments

13.16 Bespak

13.16.1 Bespak Company Information

13.16.2 Bespak Pulmonary Drug Delivery Devices Product Offered

13.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Bespak Main Business Overview

13.16.5 Bespak Latest Developments

13.17 AptarGroup

13.17.1 AptarGroup Company Information

13.17.2 AptarGroup Pulmonary Drug Delivery Devices Product Offered

13.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 AptarGroup Main Business Overview

13.17.5 AptarGroup Latest Developments

13.18 SHL Group

13.18.1 SHL Group Company Information

13.18.2 SHL Group Pulmonary Drug Delivery Devices Product Offered

13.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 SHL Group Main Business Overview

13.18.5 SHL Group Latest Developments

13.19 Nypro Healthcare

13.19.1 Nypro Healthcare Company Information

13.19.2 Nypro Healthcare Pulmonary Drug Delivery Devices Product Offered

13.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Nypro Healthcare Main Business Overview

13.19.5 Nypro Healthcare Latest Developments

13.20 Hovione

13.20.1 Hovione Company Information

13.20.2 Hovione Pulmonary Drug Delivery Devices Product Offered

13.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Hovione Main Business Overview

13.20.5 Hovione Latest Developments

13.21 Chiesi Farmaceutici S.P.A

13.21.1 Chiesi Farmaceutici S.P.A Company Information

13.21.2 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Offered

13.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Chiesi Farmaceutici S.P.A Main Business Overview

13.21.5 Chiesi Farmaceutici S.P.A Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pulmonary Drug Delivery Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pulmonary Drug Delivery Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Dry Powder Inhaler

Table 4. Major Players of Metered Dose Inhaler

Table 5. Major Players of Nebulizer

Table 6. Global Pulmonary Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 7. Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 8. Global Pulmonary Drug Delivery Devices Revenue by Type (2017-2022) & ($ million)

Table 9. Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2017-2022)

Table 10. Global Pulmonary Drug Delivery Devices Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Pulmonary Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 12. Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 13. Global Pulmonary Drug Delivery Devices Revenue by Application (2017-2022)

Table 14. Global Pulmonary Drug Delivery Devices Revenue Market Share by Application (2017-2022)

Table 15. Global Pulmonary Drug Delivery Devices Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Pulmonary Drug Delivery Devices Sales by Company (2020-2022) & (K Units)

Table 17. Global Pulmonary Drug Delivery Devices Sales Market Share by Company (2020-2022)

Table 18. Global Pulmonary Drug Delivery Devices Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Pulmonary Drug Delivery Devices Revenue Market Share by Company (2020-2022)

Table 20. Global Pulmonary Drug Delivery Devices Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Pulmonary Drug Delivery Devices Producing Area Distribution and Sales Area

Table 22. Players Pulmonary Drug Delivery Devices Products Offered

Table 23. Pulmonary Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Pulmonary Drug Delivery Devices Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Pulmonary Drug Delivery Devices Sales Market Share Geographic Region (2017-2022)

Table 28. Global Pulmonary Drug Delivery Devices Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Pulmonary Drug Delivery Devices Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Pulmonary Drug Delivery Devices Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Pulmonary Drug Delivery Devices Sales Market Share by Country/Region (2017-2022)

Table 32. Global Pulmonary Drug Delivery Devices Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Pulmonary Drug Delivery Devices Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Pulmonary Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 35. Americas Pulmonary Drug Delivery Devices Sales Market Share by Country (2017-2022)

Table 36. Americas Pulmonary Drug Delivery Devices Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Pulmonary Drug Delivery Devices Revenue Market Share by Country (2017-2022)

Table 38. Americas Pulmonary Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 39. Americas Pulmonary Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 40. Americas Pulmonary Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 41. Americas Pulmonary Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 42. APAC Pulmonary Drug Delivery Devices Sales by Region (2017-2022) & (K Units)

Table 43. APAC Pulmonary Drug Delivery Devices Sales Market Share by Region (2017-2022)

Table 44. APAC Pulmonary Drug Delivery Devices Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Pulmonary Drug Delivery Devices Revenue Market Share by Region (2017-2022)

Table 46. APAC Pulmonary Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 47. APAC Pulmonary Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 48. APAC Pulmonary Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 49. APAC Pulmonary Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 50. Europe Pulmonary Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 51. Europe Pulmonary Drug Delivery Devices Sales Market Share by Country (2017-2022)

Table 52. Europe Pulmonary Drug Delivery Devices Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Country (2017-2022)

Table 54. Europe Pulmonary Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 55. Europe Pulmonary Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 56. Europe Pulmonary Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 57. Europe Pulmonary Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Pulmonary Drug Delivery Devices

Table 67. Key Market Challenges & Risks of Pulmonary Drug Delivery Devices

Table 68. Key Industry Trends of Pulmonary Drug Delivery Devices

Table 69. Pulmonary Drug Delivery Devices Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Pulmonary Drug Delivery Devices Distributors List

Table 72. Pulmonary Drug Delivery Devices Customer List

Table 73. Global Pulmonary Drug Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Pulmonary Drug Delivery Devices Sales Market Forecast by Region

Table 75. Global Pulmonary Drug Delivery Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Pulmonary Drug Delivery Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Pulmonary Drug Delivery Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Pulmonary Drug Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Pulmonary Drug Delivery Devices Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Pulmonary Drug Delivery Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Pulmonary Drug Delivery Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Pulmonary Drug Delivery Devices Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Pulmonary Drug Delivery Devices Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Pulmonary Drug Delivery Devices Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Pulmonary Drug Delivery Devices Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Pulmonary Drug Delivery Devices Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Application (2023-2028)

Table 93. Boehringer Ingelheim GmbH Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 94. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Offered

Table 95. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Boehringer Ingelheim GmbH Main Business

Table 97. Boehringer Ingelheim GmbH Latest Developments

Table 98. Novartis AG Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 99. Novartis AG Pulmonary Drug Delivery Devices Product Offered

Table 100. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Novartis AG Main Business

Table 102. Novartis AG Latest Developments

Table 103. GlaxoSmithKline Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 104. GlaxoSmithKline Pulmonary Drug Delivery Devices Product Offered

Table 105. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. GlaxoSmithKline Main Business

Table 107. GlaxoSmithKline Latest Developments

Table 108. AstraZeneca Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 109. AstraZeneca Pulmonary Drug Delivery Devices Product Offered

Table 110. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. AstraZeneca Main Business

Table 112. AstraZeneca Latest Developments

Table 113. Teva Pharmaceutical Industries Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 114. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Offered

Table 115. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Teva Pharmaceutical Industries Main Business

Table 117. Teva Pharmaceutical Industries Latest Developments

Table 118. Merck Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 119. Merck Pulmonary Drug Delivery Devices Product Offered

Table 120. Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Merck Main Business

Table 122. Merck Latest Developments

Table 123. MannKind Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 124. MannKind Pulmonary Drug Delivery Devices Product Offered

Table 125. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. MannKind Main Business

Table 127. MannKind Latest Developments

Table 128. Bristol-Myers Squibb Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 129. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Offered

Table 130. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Bristol-Myers Squibb Main Business

Table 132. Bristol-Myers Squibb Latest Developments

Table 133. Mylan N.V Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 134. Mylan N.V Pulmonary Drug Delivery Devices Product Offered

Table 135. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Mylan N.V Main Business

Table 137. Mylan N.V Latest Developments

Table 138. Omron Corp Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 139. Omron Corp Pulmonary Drug Delivery Devices Product Offered

Table 140. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Omron Corp Main Business

Table 142. Omron Corp Latest Developments

Table 143. F. Hoffmann-La Roche Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 144. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Offered

Table 145. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. F. Hoffmann-La Roche Main Business

Table 147. F. Hoffmann-La Roche Latest Developments

Table 148. 3M Healthcare Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 149. 3M Healthcare Pulmonary Drug Delivery Devices Product Offered

Table 150. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. 3M Healthcare Main Business

Table 152. 3M Healthcare Latest Developments

Table 153. Sunovion Pharmaceuticals Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 154. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Offered

Table 155. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Sunovion Pharmaceuticals Main Business

Table 157. Sunovion Pharmaceuticals Latest Developments

Table 158. Koninklijke Philips N.V Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 159. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Offered

Table 160. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Koninklijke Philips N.V Main Business

Table 162. Koninklijke Philips N.V Latest Developments

Table 163. Gerresheimer AG Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 164. Gerresheimer AG Pulmonary Drug Delivery Devices Product Offered

Table 165. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 166. Gerresheimer AG Main Business

Table 167. Gerresheimer AG Latest Developments

Table 168. Bespak Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 169. Bespak Pulmonary Drug Delivery Devices Product Offered

Table 170. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 171. Bespak Main Business

Table 172. Bespak Latest Developments

Table 173. AptarGroup Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 174. AptarGroup Pulmonary Drug Delivery Devices Product Offered

Table 175. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 176. AptarGroup Main Business

Table 177. AptarGroup Latest Developments

Table 178. SHL Group Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 179. SHL Group Pulmonary Drug Delivery Devices Product Offered

Table 180. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 181. SHL Group Main Business

Table 182. SHL Group Latest Developments

Table 183. Nypro Healthcare Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 184. Nypro Healthcare Pulmonary Drug Delivery Devices Product Offered

Table 185. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 186. Nypro Healthcare Main Business

Table 187. Nypro Healthcare Latest Developments

Table 188. Hovione Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 189. Hovione Pulmonary Drug Delivery Devices Product Offered

Table 190. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 191. Hovione Main Business

Table 192. Hovione Latest Developments

Table 193. Chiesi Farmaceutici S.P.A Basic Information, Pulmonary Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors

Table 194. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Offered

Table 195. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 196. Chiesi Farmaceutici S.P.A Main Business

Table 197. Chiesi Farmaceutici S.P.A Latest Developments

List of Figures

Figure 1. Picture of Pulmonary Drug Delivery Devices

Figure 2. Pulmonary Drug Delivery Devices Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pulmonary Drug Delivery Devices Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pulmonary Drug Delivery Devices Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pulmonary Drug Delivery Devices Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Dry Powder Inhaler

Figure 10. Product Picture of Metered Dose Inhaler

Figure 11. Product Picture of Nebulizer

Figure 12. Global Pulmonary Drug Delivery Devices Sales Market Share by Type in 2021

Figure 13. Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2017-2022)

Figure 14. Pulmonary Drug Delivery Devices Consumed in Asthma

Figure 15. Global Pulmonary Drug Delivery Devices Market: Asthma (2017-2022) & (K Units)

Figure 16. Pulmonary Drug Delivery Devices Consumed in COPD

Figure 17. Global Pulmonary Drug Delivery Devices Market: COPD (2017-2022) & (K Units)

Figure 18. Pulmonary Drug Delivery Devices Consumed in Cystic Fibrosis

Figure 19. Global Pulmonary Drug Delivery Devices Market: Cystic Fibrosis (2017-2022) & (K Units)

Figure 20. Pulmonary Drug Delivery Devices Consumed in Other

Figure 21. Global Pulmonary Drug Delivery Devices Market: Other (2017-2022) & (K Units)

Figure 22. Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2017-2022)

Figure 23. Global Pulmonary Drug Delivery Devices Revenue Market Share by Application in 2021

Figure 24. Pulmonary Drug Delivery Devices Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Pulmonary Drug Delivery Devices Revenue Market Share by Company in 2021

Figure 26. Global Pulmonary Drug Delivery Devices Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Pulmonary Drug Delivery Devices Revenue Market Share by Geographic Region in 2021

Figure 28. Global Pulmonary Drug Delivery Devices Sales Market Share by Region (2017-2022)

Figure 29. Global Pulmonary Drug Delivery Devices Revenue Market Share by Country/Region in 2021

Figure 30. Americas Pulmonary Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 31. Americas Pulmonary Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 32. APAC Pulmonary Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 33. APAC Pulmonary Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 34. Europe Pulmonary Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 35. Europe Pulmonary Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Pulmonary Drug Delivery Devices Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Pulmonary Drug Delivery Devices Revenue 2017-2022 ($ Millions)

Figure 38. Americas Pulmonary Drug Delivery Devices Sales Market Share by Country in 2021

Figure 39. Americas Pulmonary Drug Delivery Devices Revenue Market Share by Country in 2021

Figure 40. United States Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Pulmonary Drug Delivery Devices Sales Market Share by Region in 2021

Figure 45. APAC Pulmonary Drug Delivery Devices Revenue Market Share by Regions in 2021

Figure 46. China Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Pulmonary Drug Delivery Devices Sales Market Share by Country in 2021

Figure 53. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Country in 2021

Figure 54. Germany Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share by Country in 2021

Figure 61. Egypt Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Pulmonary Drug Delivery Devices Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices in 2021

Figure 67. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices

Figure 68. Industry Chain Structure of Pulmonary Drug Delivery Devices

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450